(Reuters) - AstraZeneca has signed an agreement with Halix B.V. for manufacturing the COVID-19 vaccine being developed by the British drugmaker and the University of Oxford, the Netherlands-based biopharmaceutical firm said on Tuesday.
LEIDEN, The Netherlands, December 08, 2020 / B3C newswire / -- HALIX B.V. signed an agreement with AstraZeneca AB for large-scale commercial drug substance manufacture of AZD1222, the adenovirus vector-based COVID-19 vaccine.